高性能内窥镜吻合器械研发商Lexing Medical获得战略融资-动脉网

Lexington Medical Secures Growth Investment from Ampersand Capital Partners

CISION 等信源发布 2025-04-17 21:11



可切换为仅中文







BEDFORD, Mass.

马萨诸塞州贝德福德

，

April 17, 2025

2025年4月17日

/PRNewswire/ -- Lexington Medical ('

Lexington

列克星敦

'), a leader in minimally-invasive surgical stapling solutions, today announced a strategic investment by Ampersand Capital Partners ('Ampersand'), a private equity firm specializing in growth equity investments in the healthcare and life sciences sectors. The partnership underscores Ampersand's confidence in .

“），作为微创外科吻合解决方案的领导者，今天宣布了由安佩尔资本合伙公司（‘安佩尔’）进行的战略投资，这是一家专注于医疗保健和生命科学领域成长型股权投资的私募股权公司。此次合作凸显了安佩尔对。

Lexington's

列克星敦的

potential to redefine surgical stapling standards and positions the company for accelerated growth in product innovation, smart manufacturing, and global market expansion.

重新定义外科缝合标准的潜力，并使公司在产品创新、智能制造和全球市场扩张方面实现加速增长。

Founded in 2013 and headquartered in

成立于2013年，总部位于

Bedford, MA

马萨诸塞州贝德福德

, Lexington Medical designs and manufactures high-performance endoscopic stapling devices, which are proudly made in the

，列克星敦医疗设计并制造高性能的内窥镜吻合器装置，这些装置自豪地在美国制造。

USA

美国

and used in a wide range of surgical procedures. With international offices in

并广泛应用于各种外科手术中。在国际上设有办事处

Switzerland

瑞士

，

Australia

澳大利亚

，

Germany

德国

, and the UK, and a team of approximately 150 employees,

，以及英国，一个大约150名员工的团队，

Lexington

列克星敦

has built a patented portfolio of over 40 SKUs that are trusted by surgeons in more than 35 countries. Its flagship AEON™ and AEON™ Powered Stapling platforms are recognized as the most advanced stapling platforms available, featuring proprietary technologies that deliver superior clinical outcomes..

拥有超过40个SKU的专利组合，受到全球35个国家的外科医生信赖。其旗舰产品AEON™和AEON™电动吻合平台被公认为是目前最先进的吻合平台，具有专有技术，可提供卓越的临床效果。

'The investment from Ampersand is a testament to

“Ampersand的投资证明了

Lexington's

莱克星顿的

impressive growth and strategic vision,' said

“令人印象深刻的增长和战略眼光，”

Leon Amariglio

里昂·阿玛里格里奥

, Founder and CEO of Lexington Medical. 'This investment will expedite our innovation pipeline, expand our global reach, and create new opportunities for talented professionals to join us in shaping the future of surgical care, all while maintaining our commitment to best-in-class quality control and US manufacturing.'.

莱克星顿医疗的创始人兼首席执行官表示：“这项投资将加快我们的创新进程，扩大我们的全球影响力，并为有才华的专业人士创造加入我们的新机会，共同塑造外科护理的未来，同时坚持我们对一流质量控制和美国制造的承诺。”

Lexington

列克星敦

is an impressive company with a strong culture of innovation, exceptional leadership, and a commitment to quality and performance that is unmatched,' said Trevor Wahlbrink, General Partner at Ampersand. 'We are excited to partner with Leon and his team to further strengthen their position in surgical stapling.'.

“这是一家令人印象深刻的公司，拥有强大的创新文化、卓越的领导力，以及对质量和性能无与伦比的承诺，”Ampersand的普通合伙人特雷弗·瓦尔布林克表示，“我们很高兴能与莱昂及其团队合作，进一步巩固他们在外科吻合领域的地位。”

This partnership comes at a pivotal time as Lexington Medical expands its world-class team to meet the growing demand for its stapling solutions. Interested candidates and collaborators are invited to visit

随着Lexington Medical扩大其世界级团队以满足对其吻合解决方案日益增长的需求，这次合作正值一个关键时期。感兴趣的候选人和合作伙伴可访问

www.lexington-med.com/careers

or contact

或联系

careers@lexington-med.com

to learn more about career and partnership opportunities.

要了解更多关于职业和合作机会的信息。

About Lexington Medical

关于列克星敦医疗

Founded in 2013, Lexington Medical, Inc. is a rapidly growing

Lexington Medical, Inc. 成立于2013年，是一家快速发展的

Bedford, Massachusetts

马萨诸塞州贝德福德

-based company disrupting minimally invasive surgical stapling. Its AEON™ Endostapler sets the standard for precision, performance and clinical outcomes, trusted by surgeons in over 35 countries. Rooted in an engineering driven and talent-dense, collaborative culture,

这家基于创新的公司正在颠覆微创外科缝合领域。其AEON™ Endostapler（永恒™ 内镜吻合器）以精准、性能和临床效果树立了行业标准，赢得了全球超过35个国家外科医生的信任。公司根植于工程驱动、人才密集且富有协作精神的文化氛围。

Lexington

列克星敦

drives continuous innovation through U.S.-based design and manufacturing, working closely with leading surgeons to enhance patient outcomes. Learn more at

通过美国本土的设计和制造推动持续创新，与领先的外科医生紧密合作以改善患者预后。欲了解更多信息，请访问

www.lexington-med.com

or follow us on

或关注我们

领英

。

About Ampersand Capital Partners

关于Ampersand资本合伙人

Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with

成立于1988年的Ampersand Capital Partners是一家中型私募股权公司，

$3 billion

30亿美元

of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in

管理的资产规模，专注于医疗保健领域的成长型投资。在

Boston, MA

马萨诸塞州波士顿

, and

，以及

Amsterdam, Netherlands

荷兰阿姆斯特丹

, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors. For additional information, visit .

，Ampersand利用私募股权和运营经验的独特结合，与投资组合公司的管理团队一起创造价值并推动长期绩效。Ampersand已帮助在其核心医疗保健领域的每一个板块中建立众多市场领先的公司。欲了解更多信息，请访问。

AmpersandCapital.com

or follow us on

或关注我们

领英

。

SOURCE Lexington Medical

来源：列克星敦医疗

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻吗

FEATURED ON PRNEWSWIRE.COM?

刊登在PRNEWSWIRE.COM上？